Effect of tensiomin in ischaemic dilatative cardiomyopathy.
The effect of the angiotensin-converting enzyme inhibitor, Tensiomin, has been examined in patients suffering from ischaemic dilatative cardiomyopathy who had become unresponsive to combined vasodilatator--diuretic--digitalis therapy. The results were evaluated according to the changes in NYHA classes and echocardiographic parameters. Significant improvement was observed in response to Tensiomin in 38 of the 52 patients (73%). On the basis of the results the use of captopril (Tensiomin) is highly recommended for the treatment of ischaemic dilatative cardiomyopathy.